Metformin Gemax Pharma (Metformin Hydrochloride)

Metformin Hydrochloride activates AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and enhances peripheral glucose uptake. This dual action reduces fasting and post‑prandial blood glucose without stimulating insulin secretion.

The dosage of Metformin Gemax Pharma is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Metformin during pregnancy or lactation should be evaluated by a qualified prescriber. While some guidelines allow its use when benefits outweigh risks, the decision must be made on a case‑by‑case basis after thorough clinical assessment.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often preferred as first‑line therapy because it does not cause weight gain and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. Its cardiovascular safety profile is also favourable in many patient populations.

Metformin Gemax Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight to maintain potency.

Metformin Gemax Pharma is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or dissolving unless specifically directed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or when combined with certain contraindicated drugs. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and in patients who have received iodinated contrast media within the preceding 48 hours.